Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SHOT
SHOT logo

SHOT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
54.87M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
51.58M
EV/OCF(TTM)
--
P/S(TTM)
--
Bonk, Inc., formerly Safety Shot, Inc., is a wellness and dietary supplement company. The Company has developed Sure Shot, which is a patented wellness product that lowers blood alcohol content. In approximately 30 minutes, this product helps the body break down alcohol. Its bottles and stick packs are sold direct-to-consumer (D2C) and via retail partners. D2C orders through the Sure Shot Website are fulfilled via a 3PL with additional sales through online outlets. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. It has also introduced business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars. It also makes energy beverages with yerba mate and other plant-based ingredients. Its energy beverages are zero calorie, zero sugar, non-genetically modified organism, vegan, kosher, keto-friendly, paleo-approved, gluten-free and diabetic-friendly. The Company is focused on building a digital asset treasury.
Show More

Events Timeline

(ET)
2025-10-09
09:35:09
Safety Shot Rebrands as Bonk Inc.
select
2025-10-08 (ET)
2025-10-08
08:32:45
Safety Shot Purchases 2.7% of BONK's Circulating Supply
select
2025-09-25 (ET)
2025-09-25
09:05:19
Safety Shot collaborates with Monarq Asset Management to oversee BONK Holdings.
select
2025-09-18 (ET)
2025-09-18
09:10:43
Safety Shot shares insights on board revitalization and corporate strategy.
select
2025-09-17 (ET)
2025-09-17
08:33:37
Safety Shot Reveals Strategic Board Update to Align with Company Vision
select
2025-09-11 (ET)
2025-09-11
08:38:09
Safety Shot introduces BONK Holdings to establish a treasury within the BONK ecosystem.
select
2025-09-05 (ET)
2025-09-05
08:35:38
Safety Shot appoints Rudy to the board and announces Long's resignation.
select
2025-08-25 (ET)
2025-08-25
08:36:08
Safety Shot receives $30M funding from BONK core team and FalconX.
select

News

Newsfilter
4.5
2025-10-09Newsfilter
Safety Shot, Inc. Rebrands as Bonk, Inc. and Will Trade on Nasdaq with New Ticker Symbol "BNKK"
  • Company Rebranding: Safety Shot, Inc. has rebranded itself as Bonk, Inc. to align with its new strategic focus on the BONK ecosystem, effective October 10, 2025, with a new ticker symbol "BNKK."

  • Strategic Transformation: The rebranding marks the completion of the company's strategic pivot towards becoming a leader in the digital asset space, driven by its acquisition of a revenue-sharing interest in the memecoin launchpad letsBONK.fun and the establishment of a significant treasury of BONK tokens.

Benzinga
2.0
2025-09-26Benzinga
Top KingWin Shares Surge 87%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Top KingWin Ltd Surge: Shares of Top KingWin Ltd rose 87.4% to $5.92 in pre-market trading after announcing a sales contract for 10,000 TK-D2C AI Robots with Walker Times International.

  • Other Notable Gainers: MEDIROM Healthcare Technologies saw a 242% increase, while New Era Energy & Digital surged 37.6%, and Datavault AI gained 33% following significant announcements and investments.

  • Significant Losers: Kuke Music Holding dipped 30.5% after acquiring a controlling interest in Naxos Music Group, and Concentrix Corporation fell 20.5% due to disappointing earnings results.

  • Market Overview: The pre-market trading session showed a mix of gains and losses among various stocks, with notable movements in both directions across the board.

NASDAQ.COM
2.0
2025-09-26NASDAQ.COM
Diverse Catalysts Influence After-Hours Activity in MRM, LEXX, SHOT, AQST, and OVID
  • MEDIROM Healthcare Technologies Surge: Shares of MEDIROM Healthcare Technologies Inc. (MRM) skyrocketed 282.8% in after-hours trading after announcing plans to double the installation of its biometric authentication device "Orb" to 200 stores, reflecting strong speculative interest in AI-linked technologies.

  • Lexaria Bioscience Gains: Lexaria Bioscience Corp. (LEXX) saw a 45.75% increase in after-hours trading due to renewed focus on its DehydraTECH drug delivery platform, which enhances the delivery of GLP-1 drugs, indicating growing interest in biotech innovations.

  • Safety Shot's Strategic Shift: Safety Shot, Inc. (SHOT) experienced a 12% rise in after-hours trading following a partnership with Monarq Asset Management to manage its BONK Holdings Treasury, aligning with its strategic pivot towards digital assets.

  • Regulatory Momentum for Aquestive Therapeutics: Shares of Aquestive Therapeutics, Inc. (AQST) rose 11.41% in after-hours trading after the FDA streamlined the review process for its oral epinephrine candidate, Anaphylm, highlighting its potential as a needle-free allergy treatment.

NASDAQ.COM
2.0
2025-09-18NASDAQ.COM
CGTX, RVPH, SHOT, SONN, AKTX Surge in After-Hours Trading Following Clinical Developments and Fed Rate Cut Expectations
  • Biotech Sector Response to Economic Changes: Biotech and healthcare stocks are reacting positively to the Federal Reserve's first rate cut of 2025, which is expected to improve funding conditions for capital-intensive sectors like biotechnology. Companies are experiencing notable price movements due to clinical trial progress and regulatory developments.

  • Sonnet BioTherapeutics Update: Sonnet BioTherapeutics' shares rose significantly after announcing expanded clinical evaluation of its lead candidate for ovarian cancer, along with a strong safety profile and partial response results. Key upcoming events include a stockholder meeting and trial updates.

  • Akari Therapeutics Patent Filing: Akari Therapeutics saw a surge in its stock price following a provisional patent filing for its antibody-drug conjugate platform aimed at cancer treatment, which enhances its intellectual property and supports the development of innovative therapies.

  • Reviva Pharmaceuticals and Cognition Therapeutics Developments: Reviva Pharmaceuticals' stock increased after a revised analyst rating maintained confidence in its long-term potential, while Cognition Therapeutics announced a $30 million offering to support its Alzheimer's treatment candidate, Zervimesine, which is progressing towards Phase 3 development.

Benzinga
7.5
2025-09-12Benzinga
Millionaire Trader Favors Dogecoin and Solana ETFs Over XRP as Key Drivers for This 'Explosive' Meme Coin
  • Meme Coin Market Dynamics: Unipcs highlights that the crypto market is experiencing significant catalysts, particularly with the upcoming Dogecoin ETF and the overlooked potential of Bonk (BONK), which has recently broken out of a descending wedge pattern, indicating possible future rallies.

  • Institutional Interest in Bonk: BONK Holdings, a new subsidiary launched by Safety Shot, has acquired a substantial amount of BONK tokens and plans to enhance its Solana-based DeFi strategy, suggesting growing institutional interest and potential for significant price movements in the future.

Newsfilter
4.5
2025-09-11Newsfilter
Safety Shot Initiates BONK Holdings to Establish Treasury for $2.5 Billion BONK Ecosystem
  • Formation of BONK Holdings: Safety Shot, Inc. has established a new subsidiary, BONK Holdings LLC, to manage its digital asset strategy, significantly increasing its BONK treasury to over $63 million through a $5 million purchase.

  • Active Treasury Management: BONK Holdings plans to engage in active management of its digital assets within the Solana DeFi ecosystem, focusing on staking, providing liquidity, and yield farming to generate additional revenue streams.

  • Strategic Vision: The company aims to unlock intrinsic value for shareholders and leverage its BONK treasury for future growth, with a current valuation of digital and cash assets exceeding its market cap.

  • Revenue Generation: Safety Shot will utilize its 10% revenue share from the letsBONK.fun platform to fund ongoing acquisitions of BONK tokens, further enhancing its digital asset portfolio.

Wall Street analysts forecast SHOT stock price to rise
1 Analyst Rating
Wall Street analysts forecast SHOT stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
0.50
Averages
0.50
High
0.50
Current: 0.000
sliders
Low
0.50
Averages
0.50
High
0.50
No data

No data

Valuation Metrics

The current forward P/E ratio for Bonk Inc (SHOT.O) is 1.22, compared to its 5-year average forward P/E of -25.60. For a more detailed relative valuation and DCF analysis to assess Bonk Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-25.60
Current PE
1.22
Overvalued PE
47.15
Undervalued PE
-98.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
17.74
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
75.95
Undervalued EV/EBITDA
-40.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.41
Current PS
0.00
Overvalued PS
2.87
Undervalued PS
-0.05

Financials

AI Analysis
Annual
Quarterly

Whales Holding SHOT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Bonk Inc (SHOT) stock price today?

The current price of SHOT is 0 USD — it has increased 0

What is Bonk Inc (SHOT)'s business?

Bonk, Inc., formerly Safety Shot, Inc., is a wellness and dietary supplement company. The Company has developed Sure Shot, which is a patented wellness product that lowers blood alcohol content. In approximately 30 minutes, this product helps the body break down alcohol. Its bottles and stick packs are sold direct-to-consumer (D2C) and via retail partners. D2C orders through the Sure Shot Website are fulfilled via a 3PL with additional sales through online outlets. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. It has also introduced business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars. It also makes energy beverages with yerba mate and other plant-based ingredients. Its energy beverages are zero calorie, zero sugar, non-genetically modified organism, vegan, kosher, keto-friendly, paleo-approved, gluten-free and diabetic-friendly. The Company is focused on building a digital asset treasury.

What is the price predicton of SHOT Stock?

Wall Street analysts forecast SHOT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SHOT is0.50 USD with a low forecast of 0.50 USD and a high forecast of 0.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bonk Inc (SHOT)'s revenue for the last quarter?

Bonk Inc revenue for the last quarter amounts to 44.95K USD, decreased -93.67

What is Bonk Inc (SHOT)'s earnings per share (EPS) for the last quarter?

Bonk Inc. EPS for the last quarter amounts to 0.09 USD, decreased -156.25

How many employees does Bonk Inc (SHOT). have?

Bonk Inc (SHOT) has 8 emplpoyees as of March 12 2026.

What is Bonk Inc (SHOT) market cap?

Today SHOT has the market capitalization of 54.87M USD.